Showing results (91-100 of 174) with videos related to
Sort By:
Pageof 18
Frontiers in Oncology|March 28, 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapiesChristin Habigt, Sylvie Rottey, Iben Spanggaard, et al.Journal of Hepatology|March 8, 2013
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CBruno Sangro, Carlos Gomez-Martin, Manuel de la Mata, et al.Clinical and Translational Science|September 13, 2022
Manufacturing-dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog developmentNeeltje Steeghs, Aaron R Hansen, Glenn J Hanna, et al.The Oncologist|February 22, 2023
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal CancerJosep Tabernero, Eric Van Cutsem, Elena Garralda, et al.Oncotarget|November 17, 2016
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximabRodrigo A Toledo, Antonio Cubillo, Estela Vega, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumorsCinta Hierro, Mònica Sánchez-Guixé, Gabi Tarcic, et al.European Journal of Cancer (Oxford, England : 1990)|March 11, 2025
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancerChangsong Qi, Lin Shen, Thierry Andre, et al.Cancer Discovery|October 27, 2022
Cellular Senescence Is Immunogenic and Promotes Antitumor ImmunityInes Marin, Olga Boix, Andrea Garcia-Garijo, et al.Journal for Immunotherapy of Cancer|December 21, 2025
Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy responseDaniel Navarro-Garcia, Francesco Grussu, Christina Zatse, et al.Oral Oncology|March 29, 2023
Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patientsAlberto Hernando-Calvo, Oriol Mirallas, David Marmolejo, et al.Pageof 18